Positioning Barbados as the Caribbean’s Life Sciences Hub

BRIDGETOWN, Barbados, Nov. 14, 2025 (GLOBE NEWSWIRE) — Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a US$200 Million world–class pharmaceutical and life sciences cluster earmarked for Newton, Christ Church. The initiative is expected to attract international pharmaceutical partners, drive industrialisation through sustainable contract manufacturing, and expand laboratory and clinical research capacity in Barbados and for the wider Caribbean.

Located across 45 acres, EarlyHealth City will feature three domes totaling more than 250,000 square feet of contract manufacturing space dedicated to the production of oral solids, semi–solids, liquids, and advanced biologics. This includes integrated capabilities for cell cultivation, upstream and downstream bioprocessing, and full scale–up to commercial release under United States and European Union Good Manufacturing Practice (GMP) standards.

EHG, a global pharmaceutical services and life sciences company supporting manufacturing, clinical studies, and market access across 60 countries, has already secured Memorandum of Understandings (MOUs) with a number of clients including Acarpia Farmaceutici Srl, Bioeq AG, Formycon AG, Swedish Orphan Biovitrum (SOBI), and several Asian–, European–, and South American–based manufacturers.

The City will incorporate a fourth dome housing a Security Operations Centre (SOC), designed and managed by EHG’s business partner and Dubai’s fastest–growing cybersecurity and data protection company Cyb3r Limited. The SOC is expected to feature an AI–driven cybersecurity and data–analytics infrastructure intended to safeguard digital assets, manage regulatory data, and provide secure network operations for the life sciences cluster. The same dome will also house a 30,000 square foot high–performance cricket training facility operated by global sports company DriveFITT. That facility is expected to integrate cutting–edge biomechanics and recovery technology to enhance athletic performance and to train and nurture new generations of West Indies fast bowlers.

Prime Minister the Hon Mia Amor Mottley, SC, MP, noted that Barbados is committed to providing the infrastructure, investment, and oversight required to deliver what she called a “transformative project” for the island. She explained that “beyond infrastructure, EarlyHealth City Barbados will drive job creation and build local scientific and technical talent, allowing Barbadians to play a central role in developing a new industry. It is a cornerstone of Barbados’ economic future, embedding pharmaceutical innovation and production directly into our industrial base.”

Dr. Dan A. Renout, Chief Executive Officer of EarlyHealth Group, the driving force behind the initiative, observed that “EarlyHealth City Barbados is more than a manufacturing site. It is a platform for transformation. By combining world–class standards and building local talent and innovation, we are creating an ecosystem that strengthens supply resilience, generates skilled employment, and connects the Caribbean to the global pharmaceutical industry.”

Once complete, EarlyHealth City Barbados will host a community of more than 1,000 professionals, offering wellness amenities, restaurants, and collaborative workspaces that reflect a modern, sustainable lifestyle. Together, these facilities will form the Caribbean’s premier life sciences hub.

Senior Minister Coordinating the Productive Sector and Minister of Foreign Affairs and Foreign Trade the Hon. Kerrie Symmonds hailed EarlyHealth City Barbados as a leading example of commercial diplomacy at its finest. He noted the critical role the Embassy of Barbados in the UAE and its Ambassador Her Excellency Dr. Annalee C. Babb are playing in helping EHG develop a number of critical value propositions for the island, culminating in the proposed life sciences city.

Minister of Innovation, Industry, Science and Technology Senator the Hon. Jonathan Reid observed that “Barbados is taking decisive steps to join the ranks of countries leading in life sciences and pharmaceutical innovation, building a foundation for sustainable economic growth and global competitiveness.” The Minister lauded Export Barbados, its Chairman Mr. Dodridge Miller, and its Chief Executive Officer Mr. Mark Hill for their ingenuity and foresight in not only leading the conceptualisation of Barbados as a regional hub for the global life sciences sector, but also in designing an iconic building he believes can serve as a prototype for new approaches to high–end pharmaceutical manufacturing.


About EarlyHealth Group
EarlyHealth Group (EHG) is a global pharmaceutical services and life sciences company supporting manufacturing, clinical studies, and market access across 60 countries. The Group partners with manufacturers, research institutions, and governments to make healthcare accessible through compliant, end–to–end solutions across the value chain.

About Export Barbados
Export Barbados (BIDC) is the state–owned enterprise that drives Barbados’ industrialisation and export growth. The agency develops infrastructure, supports innovation, and partners with global companies to strengthen Barbados’ position as a competitive exporter of goods and services, with a focus on life sciences, manufacturing, and sustainable industries.

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/219aaac2–0f40–45aa–9e7f–48e56b8b2cf1

https://www.globenewswire.com/NewsRoom/AttachmentNg/53be00d8–50b2–4cbf–91dc–9b1b65b4046c

https://www.globenewswire.com/NewsRoom/AttachmentNg/036fb1db–d93f–4bde–ad18–2fdc99d5d027


GLOBENEWSWIRE (Distribution ID 1001138984)

EarlyHealth Group acquiert CYB3R, l’entreprise de cybersécurité à la croissance la plus rapide du Golfe

DUBAÏ, Émirats arabes unis, 13 oct. 2025 (GLOBE NEWSWIRE) — EarlyHealth Group, une société internationale du secteur des services pharmaceutiques et des solutions pour les sciences de la vie, a acquis une participation de 50 % dans CYB3R Limited, l’une des entreprises de cybersécurité à la croissance la plus rapide du Golfe, basée à Dubaï. Cette diversification stratégique et ces investissements intersectoriels permettent à CYB3R d’étendre sa présence à l’échelle mondiale tout en élargissant son offre de solutions clés en main destinées au secteur des sciences de la vie et aux organismes gouvernementaux.

CYB3R, fondée par les entrepreneurs du monde des technologies Alex Halsall et Jack Tupper, s’est rapidement imposée en sécurisant les infrastructures critiques et les données sensibles dans les secteurs réglementés au Moyen–Orient et en Europe. En intégrant les capacités de CYB3R à la plateforme mondiale d’EarlyHealth, ce partenariat permettra d’étendre ses opérations à l’échelle internationale et de fournir des solutions clés en main qui protègent les études cliniques, les programmes institutionnels et les initiatives gouvernementales.

« Avec un portefeuille croissant de 1 200 entreprises internationales et organismes publics, notre partenariat avec EarlyHealth marque une nouvelle étape dans le développement mondial des capacités de CYB3R et dans la fourniture de solutions de cybersécurité sur mesure à nos principaux secteurs d’activité », a déclaré Alex Halsall, directeur général de CYB3R. « Ensemble, nous établirons une nouvelle référence en matière de sécurité numérique fiable et axée sur la conformité aux normes. »

L’équipe de direction de CYB3R restera en place après l’acquisition, garantissant ainsi une continuité dans la gestion de la clientèle actuelle tout en élargissant ses capacités pour servir de nouveaux marchés mondiaux.

La troisième acquisition de EarlyHealth cette année souligne sa volonté de créer un conglomérat mondial à la croisée des chemins entre les soins de santé et la transformation numérique, en proposant des solutions innovantes qui élargissent l’accès aux patients, renforcent le secteur et consolident les capacités gouvernementales à l’échelle mondiale.

À propos d’EarlyHealth Group
EarlyHealth Group est une société internationale du secteur des services pharmaceutiques et des sciences de la vie qui soutient la fabrication, les études cliniques et l’accès au marché dans 60 pays. Le Groupe collabore avec des entreprises biopharmaceutiques, des instituts de recherche et des gouvernements afin de rendre les soins de santé accessibles grâce à des solutions conformes et complètes tout au long de la chaîne de valeur.

À propos de CYB3R
CYB3R est une entreprise de cybersécurité de pointe basée à Dubaï qui fournit des services de pointe en matière d’opérations SOC, de détection et de réponse gérées (MDR), de tests de vulnérabilité et de conseil en conformité. En mettant l’accent sur l’application de l’IA pour améliorer la maturité en matière de sécurité, la gouvernance, les risques et la conformité (GRC) ainsi que la protection des données, CYB3R sert une clientèle diversifiée qui comprend des entités gouvernementales, des prestataires de soins de santé, des institutions financières, des réseaux éducatifs et des prestataires de services internationaux.

Une photo accompagnant ce communiqué est disponible à l’adresse suivante : http://www.globenewswire.com/NewsRoom/AttachmentNg/26f5855c–3e3a–4fa3–875b–be4bf1bc69ad


GLOBENEWSWIRE (Distribution ID 1001132891)